ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Astrazeneca 31

Astrazeneca 31 (50UC)

106.475
-0.325
( -0.30% )
Updated: 03:00:21

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 63.35B60.65B61.38B66.73B105.36B96.48B101.12B104.04B
Total Current Assets 13.15B15.59B15.56B19.54B26.24B22.59B25.05B25.83B
Cash and Equivalents 3.32B4.83B5.37B7.83B6.33B6.17B5.84B5.49B
Total Non-Current Assets 16.64B14.04B14.6B15.64B39.29B37.06B39.17B40.87B
Total Liabilities 46.71B46.61B46.78B51.09B66.08B59.43B61.95B63.16B
Total Current Liabilities 16.38B16.29B18.12B20.31B22.59B26.29B30.54B27.87B
Total Non-Current Liabilities 45.89B47.67B44.88B48.78B72.37B56.82B54.63B62.92B
Total Equity 16.64B14.04B14.6B15.64B39.29B37.06B39.17B40.87B
Common Equity 317M317M328M328M387M387M388M388M
Retained Earnings 8.22B5.68B2.81B5.3B1.71B-574M1.5B3.16B

Your Recent History

Delayed Upgrade Clock